Covid-19: Panacea Biotec starts supplying second component of Sputnik V vaccine

Sputnik V

Sputnik V has demonstrated efficacy of 97.6% and has already received Emergency Usage Authorisation in India. The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and Panacea Biotec on Tuesday announced the shipment of the second component of Sputnik V vaccine produced in India by Panacea. The second jab of the Sputnik vaccine comprises … Read more